Tumor Biomarker Testing for Metastatic Colorectal Cancer: a Canadian Consensus Practice Guideline.

Yu, Irene S; Aubin, Francine; Goodwin, Rachel; Loree, Jonathan M; Mather, Cheryl; Sheffield, Brandon S; Snow, Stephanie; Gill, Sharlene

Yu, Irene S; Aubin, Francine; Goodwin, Rachel; Loree, Jonathan M; Mather, Cheryl; Sheffield, Brandon S; Snow, Stephanie; Gill, Sharlene.

Afiliação

Yu IS; Department of Medical Oncology, BC Cancer Surrey, Surrey, BC, Canada.
Aubin F; Division of Hematology and Oncology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Goodwin R; Division of Medical Oncology, Department of Medicine, Ottawa Hospital Cancer Centre, Ottawa, ON, Canada.
Loree JM; Department of Medical Oncology, BC Cancer Agency - Vancouver Centre, Vancouver, BC, Canada.
Mather C; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.
Sheffield BS; Division of Advanced Diagnostics, William Osler Health System, Brampton, ON, Canada.
Snow S; Department of Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
Gill S; Department of Medical Oncology, BC Cancer Agency - Vancouver Centre, 600 W 10th Ave, Vancouver, BC, V5Z 4E6, Canada.

Ther Adv Med Oncol ; 14: 17588359221111705, 2022.

Article em En | MEDLINE | ID: mdl-35898967

Palavras-chave

colorectal cancer; metastasis; molecular testing; predictive biomarker; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google